Table 2 Changes and comparisons of selected parameters (follow-up minus baseline)
Variables | Baseline | 12 weeks | Change |
|---|---|---|---|
FBG (mmol/L) | |||
 Active group | 7.7 ± 0.5 | 6.5 ± 0.5* | −1.2 ± 0.4 |
 Control group | 7.6 ± 0.6 | 7.3 ± 0.6# | −0.3 ± 0.2 |
HbA1c (%) | |||
 Active group | 7.9 ± 0.4 | 7.1 ± 0.5* | −0.8 ± 0.4 |
 Control group | 8.0 ± 0.4 | 7.8 ± 0.6# | −0.2 ± 0.2 |
HOMA-IR | |||
 Active group | 2.5 ± 0.4 | 1.7 ± 0.5* | −0.8 ± 0.4 |
 Control group | 2.4 ± 0.4 | 2.1 ± 0.4# | −0.3 ± 0.2 |
BMI, kg/m2 | |||
 Active group | 26.4 ± 5.0 | 25.9 ± 4.4 | −0.5 ± 0.4 |
 Control group | 26.3 ± 4.8 | 26.1 ± 4.1 | −0.2 ± 0.1 |
Waist/hip ratio | |||
 Active group | 0.83 ± 0.11 | 0.80 ± 0.10 | −0.03 ± 0.01 |
 Control group | 0.84 ± 0.10 | 0.83 ± 0.12 | −0.01 ± 0.01 |
Subcutaneous adipose tissue (cm2) | |||
 Active group | 206.7 ± 50.3 | 203.2 ± 47.1 | −3.5 ± 1.0 |
 Control group | 204.2 ± 48.8 | 201.8 ± 44.3 | −2.4 ± 0.8 |
Visceral adipose tissue (cm2) | |||
 Active group | 154.6 ± 41.8 | 146.8 ± 40.4* | −7.6 ± 2.3 |
 Control group | 152.9 ± 39.2 | 150.3 ± 38.3# | −2.6 ± 0.9 |
ALT (U/L) | |||
 Active group | 38 ± 12 | 35 ± 15 | −3 ± 2 |
 Control group | 36 ± 14 | 34 ± 14 | −2 ± 2 |
AST (U/L) | |||
 Active group | 36 ± 13 | 33 ± 11 | −3 ± 1 |
 Control group | 37 ± 13 | 34 ± 12 | −3 ± 2 |
Creatinine (μmol/L) | |||
 Active group | 1.1 ± 0.3 | 1.0 ± 0.4 | −0.1 ± 0.1 |
 Control group | 1.1 ± 0.4 | 1.0 ± 0.3 | −0.1 ± 0.1 |
C-reactive protein (mg/L) | |||
 Active group | 5.8 ± 1.2 | 3.3 ± 0.8* | −1.5 ± 0.6 |
 Control group | 5.9 ± 1.1 | 4.6 ± 0.9# | −1.3 ± 0.5 |
Nitric oxide (μmol/L) | |||
 Active group | 46.8 ± 9.6 | 52.4 ± 11.5* | 5.6 ± 0.8 |
 Control group | 45.4 ± 8.8 | 48.7 ± 9.6# | 3.3 ± 0.6 |